Previous 10 |
Histogen ( HSTO ) has completed patient dosing for the week 6 treatment timepoint in its Phase 1b/2a trial of HST-001 for the treatment of androgenic alopecia (pattern baldness) in men. More news on: Histogen Inc., Healthcare stocks news, Read more ...
SAN DIEGO, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, t...
SAN DIEGO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today a...
Histogen (NASDAQ: HSTO ) : Q2 GAAP EPS of -$1.52. More news on: Histogen Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Completed Enrollment for HST-001 Phase 1a/2b Trial for Androgenic Alopecia in Men with Topline Data Expected 4Q20 Filed IDE for HST-002 for Treatment of Moderate to Severe Nasolabial Folds Appointed Susan A. Knudson as Chief Financial Officer SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE...
News, Short Squeeze, Breakout and More Instantly...
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...
Usinas Siderurgicas De Minas Gerais S.A. ADR (Representing Pref Share Cl A) (USNZY) is expected to report $0 for Q2 2024 CREATD INC. (CRTD) is expected to report for Q1 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Senstar Technologie...
Verbund AG ADR (OEZVY) is expected to report for Q1 2024 Rent the Runway Inc. (RENT) is expected to report $-6.56 for Q1 2025 Johnson Matthey plc ADR (JMPLY) is expected to report for Q4 2024 RVL Pharmaceuticals plc (RVLPQ) is expected to report for Q1 2024 Ciena Corporation (CIEN...